507 results on '"Niwa, Akira"'
Search Results
2. A disease-specific iPS cell resource for studying rare and intractable diseases
3. Selective induction of human renal interstitial progenitor-like cell lineages from iPSCs reveals development of mesangial and EPO-producing cells
4. ZEB2 and MEIS1 independently contribute to hematopoiesis via early hematopoietic enhancer activation
5. Recapitulation of pro-inflammatory signature of monocytes with ACVR1A mutation using FOP patient-derived iPSCs
6. NUDT15 variants confer high incidence of second malignancies in children with acute lymphoblastic leukemia
7. Analysis of disease model iPSCs derived from patients with a novel Fanconi anemia–like IBMFS ADH5/ALDH2 deficiency
8. Induction of Human Natural Killer Cells Under Defined Conditions by Seamless Transition from Maintenance Culture of Pluripotent Stem Cells
9. Bidirectional myofiber transition through altering the photobiomodulation condition
10. Author Correction: Pluripotent stem cell model of Shwachman–Diamond syndrome reveals apoptotic predisposition of hemoangiogenic progenitors
11. N-Acetylcysteine prevents amyloid-β secretion in neurons derived from human pluripotent stem cells with trisomy 21
12. UK-5099, a mitochondrial pyruvate carrier inhibitor, recovers impaired neutrophil maturation caused by AK2 deficiency in human pluripotent stem cell models
13. Pluripotent Stem Cell Model of Nakajo-Nishimura Syndrome Untangles Proinflammatory Pathways Mediated by Oxidative Stress
14. Pluripotent stem cell models of Blau syndrome reveal an IFN-γ–dependent inflammatory response in macrophages
15. Improvement of multilineage hematopoiesis in hematopoietic stem cell-transferred c-kit mutant NOG-EXL humanized mice
16. Pluripotent stem cell model of Shwachman–Diamond syndrome reveals apoptotic predisposition of hemoangiogenic progenitors
17. Biomimetic aorta-gonad-mesonephros-on-a-chip to study human developmental hematopoiesis
18. Hematological Disorders
19. Lysosomal membrane permeabilization causes secretion of IL-1β in human vascular smooth muscle cells
20. Involvement of mTOR pathway in neurodegeneration in NSF-related developmental and epileptic encephalopathy
21. A disease-specific iPS cell resource for studying rare and intractable diseases
22. A concise in vitro model for evaluating interactions between macrophage and skeletal muscle cells during muscle regeneration
23. SMN promotes mitochondrial metabolic maturation during myogenesis by regulating the MYOD-miRNA axis
24. A concise in vitro model for evaluating interactions between macrophage and skeletal muscle cells during muscle regeneration
25. Prevalence of pathogenic variants in cancer‐predisposing genes in second cancer after childhood solid cancers
26. Data from Specific Antileukemic Activity of PD0332991, a CDK4/6 Inhibitor, against Philadelphia Chromosome–Positive Lymphoid Leukemia
27. Supplementary Figure from Specific Antileukemic Activity of PD0332991, a CDK4/6 Inhibitor, against Philadelphia Chromosome–Positive Lymphoid Leukemia
28. Supplementary Table from Specific Antileukemic Activity of PD0332991, a CDK4/6 Inhibitor, against Philadelphia Chromosome–Positive Lymphoid Leukemia
29. Involvement of mTOR pathway in neurodegeneration in NSF-related developmental and epileptic encephalopathy
30. SMN promotes mitochondrial metabolic maturation during myogenesis by regulating the MYOD-miRNA axis
31. Human pluripotent stem cell–derived erythropoietin-producing cells ameliorate renal anemia in mice
32. Using patient-derived iPSCs to develop humanized mouse models for chronic myelomonocytic leukemia and therapeutic drug identification, including liposomal clodronate
33. A portable platform for stepwise hematopoiesis from human pluripotent stem cells within PET-reinforced collagen sponges
34. Induced pluripotent stem cells from CINCA syndrome patients as a model for dissecting somatic mosaicism and drug discovery
35. Unique multipotent cells in adult human mesenchymal cell populations
36. Recapitulation of pro-inflammatory signature of monocytes with ACVR1A mutation using FOP patient-derived iPSCs
37. Recapitulation of pro-inflammatory signature of monocytes with ACVR1 mutation using FOP patient-derived iPSCs.
38. Additional file 1 of Recapitulation of pro-inflammatory signature of monocytes with ACVR1A mutation using FOP patient-derived iPSCs
39. Identification of a High‐Frequency Somatic NLRC4 Mutation as a Cause of Autoinflammation by Pluripotent Cell–Based Phenotype Dissection
40. SMN promotes mitochondrial metabolic maturation during myogenesis by regulating the MYOD-miRNA axis
41. iPS cells from Chediak‐Higashi syndrome patients recapitulate the giant granules in myeloid cells
42. Prognostic significance of aminopeptidase-N (CD13) in hepatoblastoma
43. Functional Delineation and Differentiation Dynamics of Human CD4+ T Cells Expressing the FoxP3 Transcription Factor
44. Dynamics of [Zn(D 2O) 6] 2+ in [Zn(D 2O) 6][SiF 6] crystal as studied by 1D, 2D spectra and spin-lattice relaxation time of 2H NMR
45. Mutant rat strain lacking d-amino-acid oxidase
46. IL-4 Acts at an Early Fate-Determining Junction in Hematopoiesis to Induce NK Cell Subsets Expressing Endogenous CD16
47. Elucidation of the Unique Function of GATA1s in the Development of Transient Abnormal Myeloproliferative Disorders
48. Screening for Intracellular Phosphorylation Cascades That Positively and Negatively Regulate the Self-Renewing Proliferation of Immature HPCs
49. Enhancement of Human Neutrophil Bactericidal Activity through ROS Regulation
50. Down syndrome-related transient abnormal myelopoiesis is attributed to a specific erythro-megakaryocytic subpopulation with GATA1 mutation
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.